Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable ...

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.

Previously confined to fringe enthusiasts, psychedelic therapy is experiencing a renaissance, championed by the singer Lorde, ...

Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...